Close Menu


OICR plans to validate the machine and develop a framework for sequencing patient tumors that can help physicians make informed decisions about treatments or clinical trial placements.

The Ontario Institute for Cancer Research plans to use the government funding to pursue its five-year strategic plans and roll-out a large clinical trial.

The work is part of a larger effort that aims to sequence the transcriptomes and whole genomes of up to 100 prostate cancer tumors.

The project will involve Canadian researchers in Vancouver, Calgary, Toronto, Kingston, and Montreal, who will collaborate with research teams in the UK, France, and Germany.

In a series of articles in Science, Francis Collins, Craig Venter, and other experts offer their insights into the original human genome sequencing effort and its implications for health, science, and society.

In its just-released Strategic Plan 2010-2015, the Ontario Institute for Cancer Research said it will step up its translation of discoveries, in part through a greater focus on personalized medicine and building partnerships with industry and other research institutions.


In a letter, about two dozen researchers criticize the World Health Organization investigation into the origins of SARS-CoV-2 and call for a new inquiry, the Wall Street Journal reports.

National Geographic reports that nine great apes at the San Diego Zoo have been vaccinated against SARS-CoV-2.

Janet Woodcock, the acting commissioner of the US Food and Drug Administration, speaks with NPR about SARS-CoV-2 testing and vaccines in the US.

In Science this week: genetic study of kidney fibrosis implicates the SOX9-NAV3-YAP1 axis.